UnitedHealth Group CEO Andrew Witty mourned the death of Brian Thompson, who led the company's insurance arm, and acknowledged that the U.S. healthcare system is "flawed" and in need of reform. In a New York Times opinion pieces, Witty made his first public comments since last week's fatal shooting of Thompson.
CEO Andrew Witty said: "We know the health system does not work as well as it should, and we understand people's frustrations with it."
One of the most publicized stories of the year has been the murder of UnitedHealth Group (NYSE: UNH) medical insurance division CEO Brian Thompson.
UnitedHealth's chief executive on Friday called for the healthcare system to be overhauled, following the emotional and angry reaction many had to the murder of one of the company's senior executives.
UnitedHealth Group CEO Andrew Witty wrote in a New York Times opinion piece on Friday that the healthcare system was flawed and was a "patchwork built over decades."
Jim Lebenthal, chief equity strategist at Cerity Partners, joins CNBC's 'Halftime Report' to discuss why he's buying more UnitedHealth.
UnitedHealth stock is continuing to fall Thursday after the introduction of bipartisan legislation targeting PBMs and healthcare giants. Here's what to know.
UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Major insurance stocks including UnitedHealth Group, Ciga Group, and Elevance have fallen up to 11% in the last five days. The decline has been pronounced since their closing prices last Tuesday, which was one day prior to the killing of UnitedHealthcare CEO Brain Thompson.
Pharmacy benefit managers have previously come under scrutiny for their influence over prescription drug prices.
Shares of UnitedHealth Group (UNH -4.74%) were pulling back again today on reports that the Senate is working on a bill that would force health insurers like UnitedHealth to divest their pharmacy benefit managers (PBMs) within three years.
Health care companies are taking a step back to better understand patients' experiences after a powerful U.S. health insurance executive was murdered last week, executives from drugmaker Pfizer and Amazon.com said at a panel at the Reuters NEXT conference in New York on Wednesday.